Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.
Guillain-Barré syndrome: clinical profile and management.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.
Natural History of Multiple Sclerosis Symptoms
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
Fingolimod modulates microglial activation to augment markers of remyelination.
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216)
The value of specialty pharmaceuticals - a systematic review.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Clinical profile of malay children with optic neuritis.
Poor sleep in patients with multiple sclerosis.
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.

Pages